View Post

STILL OPENED – Savvy Cooperative: Paid Opportunity for People Diagnosed With a Solid Tumor Cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER Eligibility Criteria: Adults who have been diagnosed with a solid tumor cancer Verification of diagnosis will be required to participate Ages 18-75 years old Are currently in active treatment Currently living in the United States Able to read, write, and speak in English Details: 60-minute interview From a home computer Receive: $100 Link: https://gigs.savvy.coop/stcancer/?r=44951 Why Sign Up? Your experiences …

View Post

Ascentage Pharma Announces IND Clearance by the US FDA for Lisaftoclax (APG-2575)

In Clinical Studies News by Barbara Jacoby

Source: Ascentage Pharma From: prnewswire.com Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Investigational New Drug (IND) application for the company’s novel Bcl-2 inhibitor, lisaftoclax (APG-2575), has been cleared by the US Food and Drug Administration (FDA) and the company is …

View Post

Cancer Fatigue: Why It Happens, How to Cope

In In The News by Barbara Jacoby

From: healthline.com What Causes Cancer-Related Fatigue and How to Manage It Fatigue is a common symptom of cancer and a side effect of some cancer treatments. Cancer fatigue is more than feeling tired or sleepy. It can feel like an overwhelming lack of energy that interferes with your daily activities. In this article, we’ll examine the connection between cancer and …

View Post

Most Oncology Trials Fail to Report Timely Results

In Clinical Studies News by Barbara Jacoby

By: Mike Bassett From: medpagetoday.com Situation steadily improving since passage of FDAAA, however While fewer than 40% of completed oncology trials in 2017 reported their results in a timely fashion, that percentage was eight times higher compared with a decade ago, researchers reported. Among more than 12,000 clinical trials registered in ClinicalTrials.gov, the percentage reporting results within 24 months of …

View Post

STILL OPENED – Savvy Cooperative: Paid Opportunity for People Diagnosed With a Solid Tumor Cancer

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER Eligibility Criteria: Adults who have been diagnosed with a solid tumor cancer Verification of diagnosis will be required to participate Ages 18-75 years old Are currently in active treatment Currently living in the United States Able to read, write, and speak in English Details: 60-minute interview From a home computer Receive: $100 Link: https://gigs.savvy.coop/stcancer/?r=44951 Why Sign Up? Your experiences …

View Post

This Rare Genetic Condition Leads to Cancer After Cancer

In In The News by Barbara Jacoby

By: Anna Funk From: discovermagazine.com People with Li-Fraumeni syndrome are susceptible to developing multiple types of early onset cancer. Researchers are working to find a way to make life easier for these patient Two-time cancer survivor JulieAnn Villa remembers her first genetic test in 2004, when she was 27. Her older brother had previously survived acute lymphoblastic leukemia, a rare …

View Post

New DNA research could help combat cancers that are resistant to current standard treatments

In Clinical Studies News by Barbara Jacoby

From: Queen’s University Belfast In a groundbreaking first, research led by Queen’s University Belfast has found thousands of ‘Achilles Heels’ or ‘cancer vulnerabilities’ in an analysis of more than 700 different cancer cell types. In future, this could lead to new ways to stop cancer cells in their tracks by using existing drugs, as well as proposing new targets for …

View Post

Lives saved by breast cancer screening outweigh harms of overdiagnosis

In In The News by Barbara Jacoby

By: Medical Journal of Australia (MJA) From: medicalxpress.com Overdiagnosis of breast cancer may be an inevitable consequence of the national population screening program, but the benefits of early diagnosis outweigh the harms of possible overtreatment, according to the authors of a Perspective published by the Medical Journal of Australia. Authors led by Dr. Vivienne Milch, Medical Director of Cancer Australia, …